- Home
- FORR vs FATE Comparison
FORR vs FATE Comparison
Compare FORR & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORR
- FATE
- Stock Information
- Founded
- FORR 1983
- FATE 2007
- Country
- FORR United States
- FATE United States
- Employees
- FORR N/A
- FATE N/A
- Industry
- FORR Diversified Commercial Services
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FORR Consumer Discretionary
- FATE Health Care
- Exchange
- FORR Nasdaq
- FATE Nasdaq
- Market Cap
- FORR 193.5M
- FATE 177.7M
- IPO Year
- FORR 1996
- FATE 2013
- Fundamental
- Price
- FORR $10.53
- FATE $1.06
- Analyst Decision
- FORR
- FATE Hold
- Analyst Count
- FORR 0
- FATE 7
- Target Price
- FORR N/A
- FATE $3.83
- AVG Volume (30 Days)
- FORR 73.4K
- FATE 2.2M
- Earning Date
- FORR 07-29-2025
- FATE 08-12-2025
- Dividend Yield
- FORR N/A
- FATE N/A
- EPS Growth
- FORR N/A
- FATE N/A
- EPS
- FORR N/A
- FATE N/A
- Revenue
- FORR $422,269,000.00
- FATE $13,335,000.00
- Revenue This Year
- FORR N/A
- FATE N/A
- Revenue Next Year
- FORR $2.04
- FATE N/A
- P/E Ratio
- FORR N/A
- FATE N/A
- Revenue Growth
- FORR N/A
- FATE 105.85
- 52 Week Low
- FORR $8.50
- FATE $0.66
- 52 Week High
- FORR $20.62
- FATE $5.92
- Technical
- Relative Strength Index (RSI)
- FORR 56.84
- FATE 41.00
- Support Level
- FORR $9.46
- FATE $1.02
- Resistance Level
- FORR $9.93
- FATE $1.22
- Average True Range (ATR)
- FORR 0.43
- FATE 0.10
- MACD
- FORR 0.09
- FATE -0.02
- Stochastic Oscillator
- FORR 72.83
- FATE 12.90
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.